Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Ian E. Krop
Based on 81 articles published since 2008
||||
Expertise Level
The expertise of Ian E. Krop ranks in the
  • Top 0.0098%
  • ... of 255,217 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 81 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Krop, Ian E   ·   Krop, Ian   ·   Krop, I   ·   Krop, I E
Work Locations
Details
Most likely:    Harvard University   Contact    
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. · MD Anderson Cancer Center, Madrid, Spain. · Yale Cancer Center, Yale University Medical Center, New Haven, CT, USA. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · F Hoffmann La-Roche Ltd, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · University Hospitals Leuven, Leuven, Belgium. · Pubmed 28526538
  • Department of Medical Oncology, Institut Curie, Paris, France. Electronic address: · Mount Vernon Cancer Centre, Northwood, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Stanford Cancer Institute, Palo Alto, CA, USA. · Medical Office Hematology, Aschaffenburg, Germany. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Duke University Medical Center, Durham, NC, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · San Raffaele Hospital, Milan, Italy. · Pubmed 28526536
  • Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. · Karmanos Cancer Institute, Detroit, Michigan. · Siteman Cancer Center, Washington University, St. Louis, Missouri. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Yale Cancer Center, New Haven, Connecticut. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. · Pubmed 28298546
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA. · Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts 02115, USA. · Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston, Massachusetts 02115, USA. · Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. · Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 28813415
2016
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA · Pubmed 27358378
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Adult Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA. · Department of Product Development Oncology, Genentech, Inc., South San Francisco, CA. · Department of Biostatistics, Genentech, Inc, South San Francisco, CA. · Department of Oncology Biomarker Development, F. Hoffmann-La Roche, Ltd., Basel, Switzerland. · Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain. · Pubmed 27428671
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Ramony Cajal University Hospital, Madrid, Spain. · University of California Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Sarah Cannon Research Institute, and Tennessee Oncology, PLLC, Nashville, TN, USA. · Pubmed 27259714
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • Breast Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. · Weill Cornell Medical College, 445 E 69th St, New York, NY, 10021, USA. · Yale University, 800 Howard Ave, New Haven, CT, 06519, USA. · Stanford Cancer Institute, Stanford University School of Medicine, 900 Blake Wilbur, Stanford, CA, 94305, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, ch-4070, Switzerland. · University of Colorado Cancer Center, 1665 Aurora Ct, Aurora, CO, 80045, USA. · Pubmed 26979312
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. · Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio. · Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. · Curis, Inc., Lexington, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · City of Hope National Medical Center, Duarte, California. · Lifespan Comprehensive Cancer Center, Warren Alpert Medical School of Brown University, Providence, Rhode Island. · Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island. · Case Western Reserve University School of Medicine, Cleveland, Ohio. · Pubmed 26842237
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA. · School of Public Health, Yale University, New Haven, Connecticut, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Pubmed 27270588
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA 02215, USA; Center for Functional Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia. · Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA. · Department of Pathology, Yale University, New Haven, CT 06520, USA. · Case Western Reserve School of Medicine, Cleveland, OH 44106, USA. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: · Pubmed 26977878
  • Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. I3S, Institute for Innovation and Research in Heath, Metabolism, Nutrition and Endocrinology group, Biochemistry Department, Faculty of Medicine, Porto University, Porto, Portugal. Department of Internal Medicine, Hospital S. João, Porto, Portugal. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Surgery, Dresden University of Technology, Dresden, Germany. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Botany and Biotechnology, St. Xaviers College, Thumba, Trivandrum, Kerala, India. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. University of Massachusetts, Boston, Massachusetts. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Mayo Clinic College of Medicine, Scottsdale, Arizona. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Zoology, Mar Ivanios College, Nalanchira, Trivandrum, Kerala, India. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Surgery, KeioUniversity School of Medicine, Tokyo, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Vienna, Austria. · Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany. · Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. PAREXEL International, Billerica, Massachusetts. · Institute of Physiology and Medicine, Jobu University, Takasaki, Gunma, Japan. · Laboratory of Angiogenesis and Neurovascular link, Vesalius Research Center, Department of Oncology, K.U. Leuven and VIB, Leuven, Belgium. · I3S, Institute for Innovation and Research in Heath, Metabolism, Nutrition and Endocrinology group, Biochemistry Department, Faculty of Medicine, Porto University, Porto, Portugal. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 26861455
  • Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: · Pubmed 26822399
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts USA. · Princess Margaret Cancer Center/University Health Network, Toronto, Ontario, M5G1L7, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, M5G2M9, Canada. · Harvard University, Cambridge, Massachusetts, USA. · Cancer Research UK, Cambridge Institute, University of Cambridge, UK, CB2 0RE. · Department of Pathology, Brigham and Women's Hospital, and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Simmons Comprehensive Cancer Center, Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. · Broad Institute, Cambridge, Massachusetts, USA. · Pubmed 26735014
  • Cancer Institute, The Second Hospital of Dalian Medical University, Dalian, China. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biochemistry, Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. · Pubmed 26640141
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harrison, New York. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Breast Cancer Research, Sarah Cannon Research Institute, Nashville, Tennessee. · Department of Medicine, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Chicago, Illinois. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Department of Medicine, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis. · Department of Medicine, Washington University School of Medicine, St Louis, Missouri. · Department of Hematology Oncology, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York. · Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. · Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Medicine, Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, Tennessee. · Pubmed 26539793
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. · Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26500061
2015
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26204261
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Hematology/Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Pubmed 26578779
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1257, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Department of Biostatistics and Computation Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1257, Boston, MA, 02215, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Belfer Institute for Applied Cancer Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA. · Pubmed 26123926
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, Duke University Medical Center, Durham. · Product Development, Oncology, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology and Breast Centre, Cantonal Hospital, St Gallen, Switzerland. · Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Biostatistics, Genentech, Inc., South San Francisco, USA. · Hematology, Medical Office, Aschaffenburg, Germany. · Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 25355722
  • Dana-Farber Cancer Institute, Boston, MA. · Dana-Farber Cancer Institute, Boston, MA · Pubmed 25800754
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • Steele Laboratory for Tumor Biology, Department of Radiation Oncology (DGD, RKJ), and Department of Medicine (SJI), Massachusetts General Hospital and Harvard Medical School, Boston, MA; PAREXEL International, Waltham, MA (MA); Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IEK). · Steele Laboratory for Tumor Biology, Department of Radiation Oncology (DGD, RKJ), and Department of Medicine (SJI), Massachusetts General Hospital and Harvard Medical School, Boston, MA; PAREXEL International, Waltham, MA (MA); Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IEK). · Pubmed 25082335
  • Dana-Farber Cancer Institute, Harvard University School of Medicine, Boston, MA, USA. Electronic address: · Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, South Korea. · MD Anderson Cancer Center, Madrid, Spain. · Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Genentech, South San Francisco, CA, USA. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Pubmed 24793816
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. · Department of Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. · Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Rodent Histopathology Core, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, MA 02115, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Cell Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: · Pubmed 25117710
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24892258
  • Authors' Affiliation: Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24135146
2013
  • Affiliation of authors: Dana-Farber Cancer Institute, Brigham & Women's Hospital, Harvard Medical School, Boston, MA. · Pubmed 24262439
  • Dana-Farber Cancer Institute, Harvard University School of Medicine, Breast Oncology Center, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23629473
2012
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215, USA. · Pubmed 22649126
  • Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 22393794
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 22225715
2010
  • Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. · Pubmed 20421541
2017
  • Ian Krop, Dana-Farber Cancer Institute, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Fabrice Andre, Institute Gustave Roussy, Paris, France; Robert C. Bast, The University of Texas MD Anderson Cancer Center, Houston; Robert G. Mennel, Baylor University Medical Center, Texas Oncology PA, Dallas, TX; William Barlow, Cancer Research and Biostatistics, Seattle, WA; Deborah E. Collyar, Patient Advocates in Research, Danville, CA; M. Elizabeth Hammond, University of Utah and Intermountain Health Care, Salt Lake City, UT; Nicole M. Kuderer, University of Washington Medical Center, Seattle, WA; Minetta C. Liu, Mayo Clinic College of Medicine, Rochester, MN; Catherine Van Poznak, University of Michigan, Ann Arbor, MI; and Antonio C. Wolff and Vered Stearns, Johns Hopkins University, Baltimore, MD. · Pubmed 28692382
2016
  • Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN. · Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN. · Pubmed 26834058
  • Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Pubmed 26527775
  • N. Lynn Henry, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Vandana G. Abramson, Vanderbilt-Ingram Cancer Center, Nashville, TN; Kimberly H. Allison, Stanford University Medical Center, Stanford; Diana T. Chingos, University of Southern California/Young Survival Coalition, Los Angeles; Arti Hurria, City of Hope, Duarte, CA; Carey K. Anders, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Thomas H. Openshaw, Eastern Maine Medical Center Cancer Care, Brewer, ME; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · N. Lynn Henry, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Vandana G. Abramson, Vanderbilt-Ingram Cancer Center, Nashville, TN; Kimberly H. Allison, Stanford University Medical Center, Stanford; Diana T. Chingos, University of Southern California/Young Survival Coalition, Los Angeles; Arti Hurria, City of Hope, Duarte, CA; Carey K. Anders, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Thomas H. Openshaw, Eastern Maine Medical Center Cancer Care, Brewer, ME; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27001586
2015
  • From the *Breast Cancer Research, Sarah Cannon Research Institute; and †Medical Oncology, Tennessee Oncology, PLLC, Nashville, TN; ‡Dana-Farber Cancer Institute, Boston, MA; §Smilow Cancer Center, Yale University, New Haven, CT; ∥AdvancedBC.org, New York, NY; ¶Genentech, Inc, South San Francisco, CA; and #Mayo Clinic, Jacksonville, FL. · Pubmed 26389758
  • Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Pubmed 26169615
  • Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Pubmed 25713436
  • Departments of Breast Medical Oncology (AMGA, SL, SMT), Systems Biology (AMGA, GBM), Biostatistics (HC, YL, K-AD), Experimental Therapeutics (KSC), Investigational Cancer Therapeutics (AA, ET, SPP, VV-B, FMB), Pathology (AAS) and Surgical Oncology (FMB), The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IK, EPW); Division of Hematology-Oncology, University of California, San Diego, CA (RK); Cancer Therapy Evaluation Program, NIH/National Cancer Institute, Rockville, MD (LAD). · Departments of Breast Medical Oncology (AMGA, SL, SMT), Systems Biology (AMGA, GBM), Biostatistics (HC, YL, K-AD), Experimental Therapeutics (KSC), Investigational Cancer Therapeutics (AA, ET, SPP, VV-B, FMB), Pathology (AAS) and Surgical Oncology (FMB), The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IK, EPW); Division of Hematology-Oncology, University of California, San Diego, CA (RK); Cancer Therapy Evaluation Program, NIH/National Cancer Institute, Rockville, MD (LAD). · Pubmed 25688104
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA, · Pubmed 25537644
2014
  • Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando; Edith A. Perez, Mayo Clinic, Jacksonville; Jennifer Levinson, Ponte Vedra Beach, FL; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Ian Krop, Eric P. Winter, and Nancy U. Lin, Dana-Farber Cancer Institute, Boston, MA; and Jane Perlmutter, Ann Arbor, MI. · Pubmed 24799487
  • Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Ian Krop, Nancy U. Lin, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jennifer Levinson, Ponte Vedra Beach; Edith A. Perez, Mayo Clinic, Jacksonville; Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando, FL; and Jane Perlmutter, Ann Arbor, MI. · Pubmed 24799465
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24464780
  • Véronique Diéras, Institut Curie, Paris, France; Nadia Harbeck, University of Munich, Munich, Germany; G. Thomas Budd, Cleveland Clinic, Lerner College of Medicine, Cleveland, OH; Joel K. Greenson, University of Michigan, Ann Arbor, MI; Ellie A. Guardino, Meghna Samant, Nataliya Chernyukhin, and Melanie C. Smitt, Genentech, South San Francisco, CA; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · Véronique Diéras, Institut Curie, Paris, France; Nadia Harbeck, University of Munich, Munich, Germany; G. Thomas Budd, Cleveland Clinic, Lerner College of Medicine, Cleveland, OH; Joel K. Greenson, University of Michigan, Ann Arbor, MI; Ellie A. Guardino, Meghna Samant, Nataliya Chernyukhin, and Melanie C. Smitt, Genentech, South San Francisco, CA; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25024070
2013
  • Authors' Affiliation: Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 23942091
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
  • Brigham and Women's Hopspital, Boston, MA, USA, · Pubmed 24026859
  • Department of Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 23645007
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 24113744
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Breast Oncology Center, Boston, MA 02215, USA. · Pubmed 23829891
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23580068
2012
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21531783
2011
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 21697017
2010
  • Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 20634194
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 20461092
  • Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Harvard Medical School, University of Massachusetts, Boston, Massachusetts, USA. · Pubmed 20197472
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 81 total) written by Ian E. Krop about Breast Neoplasms:

  • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update. 2017
  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). 2017
  • 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 2017
  • Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial. 2017
  • Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. 2017
  • (no title) 2017
  • CDK4/6 inhibition triggers anti-tumour immunity. 2017
  • PIK3CA mutations in HER2-positive breast cancer: an ongoing conundrum. 2016
  • Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer. 2016
  • HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer. 2016
Show List of Full Article Records
Google Searches

Learn more about Ian E. Krop using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. · MD Anderson Cancer Center, Madrid, Spain. · Yale Cancer Center, Yale University Medical Center, New Haven, CT, USA. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · F Hoffmann La-Roche Ltd, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · University Hospitals Leuven, Leuven, Belgium. · Pubmed 28526538
  • Department of Medical Oncology, Institut Curie, Paris, France. Electronic address: · Mount Vernon Cancer Centre, Northwood, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Stanford Cancer Institute, Palo Alto, CA, USA. · Medical Office Hematology, Aschaffenburg, Germany. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Duke University Medical Center, Durham, NC, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · San Raffaele Hospital, Milan, Italy. · Pubmed 28526536
  • Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. · Karmanos Cancer Institute, Detroit, Michigan. · Siteman Cancer Center, Washington University, St. Louis, Missouri. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Yale Cancer Center, New Haven, Connecticut. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Merrimack Pharmaceuticals, Inc, Cambridge, Massachusetts. · Pubmed 28298546
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA. · Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts 02115, USA. · Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston, Massachusetts 02115, USA. · Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. · Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 28813415
2016
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA · Pubmed 27358378
  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Adult Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA. · Department of Product Development Oncology, Genentech, Inc., South San Francisco, CA. · Department of Biostatistics, Genentech, Inc, South San Francisco, CA. · Department of Oncology Biomarker Development, F. Hoffmann-La Roche, Ltd., Basel, Switzerland. · Department of Medical Oncology, MD Anderson Cancer Center, Madrid, Spain. · Pubmed 27428671
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Ramony Cajal University Hospital, Madrid, Spain. · University of California Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Sunnybrook Odette Cancer Centre, Toronto, Canada. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Merrimack Pharmaceuticals, Inc., 1 Kendall Square, Suite B7201, Cambridge, MA, 02139-1670, USA. · Sarah Cannon Research Institute, and Tennessee Oncology, PLLC, Nashville, TN, USA. · Pubmed 27259714
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • Breast Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. · Weill Cornell Medical College, 445 E 69th St, New York, NY, 10021, USA. · Yale University, 800 Howard Ave, New Haven, CT, 06519, USA. · Stanford Cancer Institute, Stanford University School of Medicine, 900 Blake Wilbur, Stanford, CA, 94305, USA. · Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. · F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Basel, ch-4070, Switzerland. · University of Colorado Cancer Center, 1665 Aurora Ct, Aurora, CO, 80045, USA. · Pubmed 26979312
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. · Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio. · Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. · Curis, Inc., Lexington, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · City of Hope National Medical Center, Duarte, California. · Lifespan Comprehensive Cancer Center, Warren Alpert Medical School of Brown University, Providence, Rhode Island. · Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island. · Case Western Reserve University School of Medicine, Cleveland, Ohio. · Pubmed 26842237
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA. · School of Public Health, Yale University, New Haven, Connecticut, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Pubmed 27270588
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA 02215, USA; Center for Functional Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia. · Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA. · Department of Pathology, Yale University, New Haven, CT 06520, USA. · Case Western Reserve School of Medicine, Cleveland, OH 44106, USA. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: · Pubmed 26977878
  • Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. I3S, Institute for Innovation and Research in Heath, Metabolism, Nutrition and Endocrinology group, Biochemistry Department, Faculty of Medicine, Porto University, Porto, Portugal. Department of Internal Medicine, Hospital S. João, Porto, Portugal. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Surgery, Dresden University of Technology, Dresden, Germany. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Botany and Biotechnology, St. Xaviers College, Thumba, Trivandrum, Kerala, India. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. University of Massachusetts, Boston, Massachusetts. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Mayo Clinic College of Medicine, Scottsdale, Arizona. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Zoology, Mar Ivanios College, Nalanchira, Trivandrum, Kerala, India. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Surgery, KeioUniversity School of Medicine, Tokyo, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Vienna, Austria. · Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany. · Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. PAREXEL International, Billerica, Massachusetts. · Institute of Physiology and Medicine, Jobu University, Takasaki, Gunma, Japan. · Laboratory of Angiogenesis and Neurovascular link, Vesalius Research Center, Department of Oncology, K.U. Leuven and VIB, Leuven, Belgium. · I3S, Institute for Innovation and Research in Heath, Metabolism, Nutrition and Endocrinology group, Biochemistry Department, Faculty of Medicine, Porto University, Porto, Portugal. · Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. · Pubmed 26861455
  • Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: · Pubmed 26822399
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts USA. · Princess Margaret Cancer Center/University Health Network, Toronto, Ontario, M5G1L7, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, M5G2M9, Canada. · Harvard University, Cambridge, Massachusetts, USA. · Cancer Research UK, Cambridge Institute, University of Cambridge, UK, CB2 0RE. · Department of Pathology, Brigham and Women's Hospital, and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Simmons Comprehensive Cancer Center, Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. · Broad Institute, Cambridge, Massachusetts, USA. · Pubmed 26735014
  • Cancer Institute, The Second Hospital of Dalian Medical University, Dalian, China. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biochemistry, Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. · Pubmed 26640141
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harrison, New York. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Breast Cancer Research, Sarah Cannon Research Institute, Nashville, Tennessee. · Department of Medicine, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Chicago, Illinois. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Department of Medicine, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis. · Department of Medicine, Washington University School of Medicine, St Louis, Missouri. · Department of Hematology Oncology, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York. · Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. · Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Medicine, Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, Tennessee. · Pubmed 26539793
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. · Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26500061
2015
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26204261
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Hematology/Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Pubmed 26578779
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1257, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Department of Biostatistics and Computation Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1257, Boston, MA, 02215, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Belfer Institute for Applied Cancer Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA. · Pubmed 26123926
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, Duke University Medical Center, Durham. · Product Development, Oncology, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology and Breast Centre, Cantonal Hospital, St Gallen, Switzerland. · Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Biostatistics, Genentech, Inc., South San Francisco, USA. · Hematology, Medical Office, Aschaffenburg, Germany. · Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 25355722
  • Dana-Farber Cancer Institute, Boston, MA. · Dana-Farber Cancer Institute, Boston, MA · Pubmed 25800754
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • Steele Laboratory for Tumor Biology, Department of Radiation Oncology (DGD, RKJ), and Department of Medicine (SJI), Massachusetts General Hospital and Harvard Medical School, Boston, MA; PAREXEL International, Waltham, MA (MA); Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IEK). · Steele Laboratory for Tumor Biology, Department of Radiation Oncology (DGD, RKJ), and Department of Medicine (SJI), Massachusetts General Hospital and Harvard Medical School, Boston, MA; PAREXEL International, Waltham, MA (MA); Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IEK). · Pubmed 25082335
  • Dana-Farber Cancer Institute, Harvard University School of Medicine, Boston, MA, USA. Electronic address: · Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, South Korea. · MD Anderson Cancer Center, Madrid, Spain. · Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Genentech, South San Francisco, CA, USA. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Pubmed 24793816
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. · Department of Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. · Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Rodent Histopathology Core, Dana Farber/Harvard Cancer Center, Harvard Medical School, Boston, MA 02115, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Cell Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: · Pubmed 25117710
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24892258
  • Authors' Affiliation: Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24135146
2013
  • Affiliation of authors: Dana-Farber Cancer Institute, Brigham & Women's Hospital, Harvard Medical School, Boston, MA. · Pubmed 24262439
  • Dana-Farber Cancer Institute, Harvard University School of Medicine, Breast Oncology Center, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23629473
2012
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215, USA. · Pubmed 22649126
  • Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 22393794
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 22225715
2010
  • Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. · Pubmed 20421541
2017
  • Ian Krop, Dana-Farber Cancer Institute, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Fabrice Andre, Institute Gustave Roussy, Paris, France; Robert C. Bast, The University of Texas MD Anderson Cancer Center, Houston; Robert G. Mennel, Baylor University Medical Center, Texas Oncology PA, Dallas, TX; William Barlow, Cancer Research and Biostatistics, Seattle, WA; Deborah E. Collyar, Patient Advocates in Research, Danville, CA; M. Elizabeth Hammond, University of Utah and Intermountain Health Care, Salt Lake City, UT; Nicole M. Kuderer, University of Washington Medical Center, Seattle, WA; Minetta C. Liu, Mayo Clinic College of Medicine, Rochester, MN; Catherine Van Poznak, University of Michigan, Ann Arbor, MI; and Antonio C. Wolff and Vered Stearns, Johns Hopkins University, Baltimore, MD. · Pubmed 28692382
2016
  • Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN. · Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN. · Pubmed 26834058
  • Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Pubmed 26527775
  • N. Lynn Henry, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Vandana G. Abramson, Vanderbilt-Ingram Cancer Center, Nashville, TN; Kimberly H. Allison, Stanford University Medical Center, Stanford; Diana T. Chingos, University of Southern California/Young Survival Coalition, Los Angeles; Arti Hurria, City of Hope, Duarte, CA; Carey K. Anders, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Thomas H. Openshaw, Eastern Maine Medical Center Cancer Care, Brewer, ME; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · N. Lynn Henry, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Vandana G. Abramson, Vanderbilt-Ingram Cancer Center, Nashville, TN; Kimberly H. Allison, Stanford University Medical Center, Stanford; Diana T. Chingos, University of Southern California/Young Survival Coalition, Los Angeles; Arti Hurria, City of Hope, Duarte, CA; Carey K. Anders, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Thomas H. Openshaw, Eastern Maine Medical Center Cancer Care, Brewer, ME; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 27001586
2015
  • From the *Breast Cancer Research, Sarah Cannon Research Institute; and †Medical Oncology, Tennessee Oncology, PLLC, Nashville, TN; ‡Dana-Farber Cancer Institute, Boston, MA; §Smilow Cancer Center, Yale University, New Haven, CT; ∥AdvancedBC.org, New York, NY; ¶Genentech, Inc, South San Francisco, CA; and #Mayo Clinic, Jacksonville, FL. · Pubmed 26389758
  • Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Pubmed 26169615
  • Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA; Thomas M. Suter, Bern University Hospital, Bern, Switzerland; Chau T. Dang, Memorial Sloan Kettering Cancer Center, New York; Marc L. Citron, Hofstra North Shore-Long Island Jewish School of Medicine, New Hyde Park, NY; Luc Dirix, Sint-Augustinus Hospital, Antwerp, Belgium; Gilles Romieu, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier; Mario Campone, Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint-Herblain, France; Claudio Zamagni, Policlinico Sant'Orsola-Malpighi Hospital, Bologna; Luca Gianni, San Raffaele Hospital, Milan, Italy; and Na Xu and Melanie Smitt, Genentech, South San Francisco, CA. · Pubmed 25713436
  • Departments of Breast Medical Oncology (AMGA, SL, SMT), Systems Biology (AMGA, GBM), Biostatistics (HC, YL, K-AD), Experimental Therapeutics (KSC), Investigational Cancer Therapeutics (AA, ET, SPP, VV-B, FMB), Pathology (AAS) and Surgical Oncology (FMB), The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IK, EPW); Division of Hematology-Oncology, University of California, San Diego, CA (RK); Cancer Therapy Evaluation Program, NIH/National Cancer Institute, Rockville, MD (LAD). · Departments of Breast Medical Oncology (AMGA, SL, SMT), Systems Biology (AMGA, GBM), Biostatistics (HC, YL, K-AD), Experimental Therapeutics (KSC), Investigational Cancer Therapeutics (AA, ET, SPP, VV-B, FMB), Pathology (AAS) and Surgical Oncology (FMB), The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IK, EPW); Division of Hematology-Oncology, University of California, San Diego, CA (RK); Cancer Therapy Evaluation Program, NIH/National Cancer Institute, Rockville, MD (LAD). · Pubmed 25688104
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA, · Pubmed 25537644
2014
  • Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando; Edith A. Perez, Mayo Clinic, Jacksonville; Jennifer Levinson, Ponte Vedra Beach, FL; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Ian Krop, Eric P. Winter, and Nancy U. Lin, Dana-Farber Cancer Institute, Boston, MA; and Jane Perlmutter, Ann Arbor, MI. · Pubmed 24799487
  • Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Ian Krop, Nancy U. Lin, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jennifer Levinson, Ponte Vedra Beach; Edith A. Perez, Mayo Clinic, Jacksonville; Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando, FL; and Jane Perlmutter, Ann Arbor, MI. · Pubmed 24799465
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24464780
  • Véronique Diéras, Institut Curie, Paris, France; Nadia Harbeck, University of Munich, Munich, Germany; G. Thomas Budd, Cleveland Clinic, Lerner College of Medicine, Cleveland, OH; Joel K. Greenson, University of Michigan, Ann Arbor, MI; Ellie A. Guardino, Meghna Samant, Nataliya Chernyukhin, and Melanie C. Smitt, Genentech, South San Francisco, CA; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · Véronique Diéras, Institut Curie, Paris, France; Nadia Harbeck, University of Munich, Munich, Germany; G. Thomas Budd, Cleveland Clinic, Lerner College of Medicine, Cleveland, OH; Joel K. Greenson, University of Michigan, Ann Arbor, MI; Ellie A. Guardino, Meghna Samant, Nataliya Chernyukhin, and Melanie C. Smitt, Genentech, South San Francisco, CA; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25024070
2013
  • Authors' Affiliation: Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 23942091
  • From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. · Pubmed 23714441
  • Brigham and Women's Hopspital, Boston, MA, USA, · Pubmed 24026859
  • Department of Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 23645007
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 24113744
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Breast Oncology Center, Boston, MA 02215, USA. · Pubmed 23829891
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23580068
2012
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21531783
2011
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 21697017
2010
  • Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 20634194
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 20461092
  • Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Harvard Medical School, University of Massachusetts, Boston, Massachusetts, USA. · Pubmed 20197472
71 Other Locations Show
Yearly article counts 0717141112115400
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.